tiprankstipranks
Astellas Pharma Inc (DE:YPH)
FRANKFURT:YPH

Astellas Pharma (YPH) Cash flow

1 Followers

Astellas Pharma Cash Flow

DE:YPH's free cash flow for Q3 2022 was ¥51.58B. For the 2022 fiscal year, DE:YPH's free cash flow was decreased by ¥-48.41B and operating cash flow was ¥72.32B. See a summary of the company’s cash flow.
Cash Flow
TTM
Mar 22Mar 21Mar 20Mar 19Mar 18
Operating Cash Flow
¥ 169.73B¥ 257.44B¥ 306.84B¥ 222.00B¥ 258.63B¥ 312.61B
Investing Cash Flow
¥ -61.09B¥ -62.41B¥ -81.89B¥ -389.79B¥ -41.76B¥ -121.80B
Financing Cash Flow
¥ -131.32B¥ -216.30B¥ -229.48B¥ 181.06B¥ -233.68B¥ -203.43B
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
¥ 1.01T¥ 315.99B¥ 326.13B¥ 318.39B¥ 311.07B¥ 331.73B
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
------
Issuance Of Debt
-¥ 0.00¥ 80.00B¥ 326.00B--
Repayment Of Debt
¥ -20.00B¥ -60.00B¥ -206.00B---
Free Cash Flow
¥ 113.47B¥ 181.00B¥ 229.40B¥ 144.11B¥ 206.50B¥ 272.33B
Domestic Sales
------
Foreign Sales
------
Currency in JPY

Astellas Pharma Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis